GB9822241D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9822241D0
GB9822241D0 GBGB9822241.7A GB9822241A GB9822241D0 GB 9822241 D0 GB9822241 D0 GB 9822241D0 GB 9822241 A GB9822241 A GB 9822241A GB 9822241 D0 GB9822241 D0 GB 9822241D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9822241.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9822241.7A priority Critical patent/GB9822241D0/en
Publication of GB9822241D0 publication Critical patent/GB9822241D0/en
Priority to PCT/EP1999/007760 priority patent/WO2000021949A1/en
Priority to AU63394/99A priority patent/AU6339499A/en
Priority to ARP990105103A priority patent/AR024219A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • C07D215/46Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB9822241.7A 1998-10-12 1998-10-12 Novel compounds Ceased GB9822241D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9822241.7A GB9822241D0 (en) 1998-10-12 1998-10-12 Novel compounds
PCT/EP1999/007760 WO2000021949A1 (en) 1998-10-12 1999-10-05 Quinolones as t-rna synthetase inhibitors and antibacterial agents
AU63394/99A AU6339499A (en) 1998-10-12 1999-10-05 Quinolones as t-rna synthetase inhibitors and antibacterial agents
ARP990105103A AR024219A1 (en) 1998-10-12 1999-10-08 COMPOUNDS OF QUINOLONES 2- (NH- OR O-SUBSTITUTES) USEFUL AS INHIBITORS OF THE METIONIL t-RNA SYNTHEASE (MRS) PHARMACEUTICAL COMPOSITIONS FORMULATED COMPOUND CONDICHES; PROCEDURE FOR THE PREPARATION AND USE OF SUCH COMPOUNDS TO PREPARE MEDICINES FOR THE TREATMENT OF BACTER INFECTIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9822241.7A GB9822241D0 (en) 1998-10-12 1998-10-12 Novel compounds

Publications (1)

Publication Number Publication Date
GB9822241D0 true GB9822241D0 (en) 1998-12-09

Family

ID=10840422

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9822241.7A Ceased GB9822241D0 (en) 1998-10-12 1998-10-12 Novel compounds

Country Status (4)

Country Link
AR (1) AR024219A1 (en)
AU (1) AU6339499A (en)
GB (1) GB9822241D0 (en)
WO (1) WO2000021949A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000071524A1 (en) * 1999-05-19 2000-11-30 Smithkline Beecham Plc 2-nh-pyridones and pyrimidones as mrs inhibitors
GB9911594D0 (en) * 1999-05-19 1999-07-21 Smithkline Beecham Plc Novel compounds
US20030105073A1 (en) * 2001-10-23 2003-06-05 Haughan Alan Findlay Quinolone derivatives
GB0302546D0 (en) * 2003-02-04 2003-03-12 Glaxo Group Ltd Novel compounds
US20040224981A1 (en) * 2003-05-01 2004-11-11 Nebojsa Janjic Antibacterial methods and compositions
EP2094714B1 (en) * 2006-09-26 2012-08-15 Crestone, Inc. Substituted thienopyridone compounds with antibacterial activity
US7973050B2 (en) 2006-09-26 2011-07-05 Crestone, Inc. Enantiomeric compounds with antibacterial activity
US7994192B2 (en) 2006-09-26 2011-08-09 Crestone, Inc. Substituted thienopyridone compounds with antibacterial activity
WO2008039640A2 (en) * 2006-09-26 2008-04-03 Crestone, Inc. Enantiomeric compounds with antibacterial activity
US8697720B2 (en) 2006-09-26 2014-04-15 Crestone, Inc. Substituted phenylether-thienopyridone compounds with antibacterial activity
US8658670B2 (en) 2006-09-26 2014-02-25 Crestone, Inc. Methods and compounds for treatment of clostridium based infection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005205A (en) * 1974-04-24 1977-01-25 Smith Kline & French Laboratories Limited Compositions and methods for inhibiting H2 histamine receptors
GB8332091D0 (en) * 1983-12-01 1984-01-11 Smith Kline French Lab Chemical compounds
EP0712405A1 (en) * 1993-08-13 1996-05-22 Smithkline Beecham Plc Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity
WO1997005132A1 (en) * 1995-07-28 1997-02-13 Cubist Pharmaceuticals, Inc. Aminoacyl adenylate mimics as novel antimicrobial and antiparasitic agents
US5824657A (en) * 1997-03-18 1998-10-20 Cubist Pharmaceuticals, Inc. Aminoacyl sulfamides for the treatment of hyperproliferative disorders
KR20010043131A (en) * 1998-04-29 2001-05-25 피터 기딩스 Quinolones Used as MRS Inhibitors and Bactericides

Also Published As

Publication number Publication date
WO2000021949A1 (en) 2000-04-20
AR024219A1 (en) 2002-09-25
AU6339499A (en) 2000-05-01

Similar Documents

Publication Publication Date Title
GB9803411D0 (en) Novel compounds
GB9801392D0 (en) Novel compounds
GB9822241D0 (en) Novel compounds
GB9802824D0 (en) Novel compounds
GB9802646D0 (en) Novel compounds
GB9801633D0 (en) Novel compounds
GB9801632D0 (en) Novel compounds
GB9802807D0 (en) Novel compounds
GB9801630D0 (en) Novel compounds
GB9801634D0 (en) Novel compounds
GB9800337D0 (en) Novel compounds
GB9800324D0 (en) Novel compounds
GB9800289D0 (en) Novel compounds
GB9801635D0 (en) Novel compounds
GB9801643D0 (en) Novel compounds
GB9801882D0 (en) Novel compounds
GB9802533D0 (en) Novel compounds
GB9802638D0 (en) Novel compounds
GB9802639D0 (en) Novel compounds
GB9814029D0 (en) Novel compounds
GB9805194D0 (en) Novel compounds
GB9803567D0 (en) Novel compounds
GB9803566D0 (en) Novel compounds
GB9803306D0 (en) Novel compounds
GB9803290D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)